HPV recombinant vaccine (4-valent) / HPV recombinant vaccine (9-valent)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HPV recombinant vaccine (4-valent) / HPV recombinant vaccine (9-valent), covering 2022-02-25 to 2022-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females [Phase 3]